Skip to main content
Ingredients/Compound/Morus Alba

Morus Alba.

Read pending.Morus Alba is in the library; the clinical read is in the queue.

Research-backed compound with potential health benefits. Tree native to China. Leaves traditionally used for blood sugar.

250 to 1,000mgDaily amount14,169Studies read

Reviewed March 2026

MACompound
Morus AlbaIngredientMD
Category
Compound

What Morus Alba is, and what it does.

Does it work
Legitimate blood sugar support. Works best alongside diet changes.
How much to take
Start with 250 to 1,000mg a day, taken with the first bites of a carbohydrate meal. The extract works in the gut lumen, so timing with food matters as much as the amount.
Time to feel it
It acts on the meal in front of you, so its effect on how quickly glucose appears happens inside that same hour. Nothing needs to build up first.
The first dose
Often uneventful. After a starchy meal some people notice gas or fullness a few hours later, as spared carbohydrate reaches the colon. That is the mechanism showing up.
With regular use
Weeks of daily use with meals show up on post-meal glucose readings more than in how you feel. Gut noise usually settles as your bacteria adapt.
How well tolerated
Generally well tolerated. Gas, bloating and looser stools are the common complaints. Talk to your doctor first if you take glucose-lowering medication.
How it feels
Mostly unremarkable, apart from a steadier stretch after a big carbohydrate meal instead of the heavy dip some people get. A bit more gas in week one is normal.
The overlooked benefit
It can only act on carbohydrate eaten at the same sitting. Taken with a low-carb meal there is almost no substrate for it to work on, so timing is the whole game.

250 to 1,000mg a day is where Morus Alba works.

How much to take a dayMedium confidence
250 to 1,000mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
2,000mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 3,000mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑01,000mg2,000mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Kimura et al., Fitoterapia, 2007; Thaipitakwong et al., PLoS ONE, 2018

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Read pending.

Morus Alba is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.

  • alpha-glucosidase inhibition at the brush borderIn vitro study
  • post-meal glucose responseRandomised trial
  • healthy insulin response after carbohydrateRandomised trial
  • blood lipids already in the normal rangeRandomised trial
  • flavonol and chlorogenic acid antioxidant capacityIn vitro study
  • body weight and compositionRandomised trial
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI14,169 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI14,169 studies readLabs test. IngredientMD verifies.
Pairs well with21 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Morus Alba + Salacia Reticulatashared alpha-glucosidase inhibition

Mulberry leaf supplies 1-deoxynojirimycin and Salacia supplies salacinol and kotalanol, and all three inhibit intestinal alpha-glucosidase at the brush border. Together they slow the same starch-to-glucose step, so the effect on the post-meal glucose rise is additive.

Morus Alba + Banaba Leaf (Corosolic Acid)different steps of glucose handling

Mulberry acts in the gut lumen by slowing carbohydrate hydrolysis while corosolic acid acts at the cell by promoting glucose transporter movement to the membrane. The two sit either side of absorption rather than duplicating each other.

Morus Alba + Gymnema Sylvestrecomplementary sugar handling

Gymnemic acids interfere with sweet taste receptors and with intestinal glucose uptake, while mulberry DNJ blocks the enzymatic release of glucose from starch upstream of that. They cover different points in the same post-meal sequence.

Morus Alba + Berberinegut-side and cell-side mechanisms

Mulberry limits how fast glucose enters from the lumen and berberine acts inside the cell through AMP-activated protein kinase signalling. Formulas combine them because neither mechanism substitutes for the other.

Morus Alba + Cinnamon Extractlong-standing formulation pairing

Cinnamon polyphenols act on insulin receptor signalling downstream of absorption while mulberry limits carbohydrate breakdown in the lumen. The pairing is standard in blends aimed at normal post-meal glucose handling.

Chromium contributes to normal insulin signalling as part of the chromodulin complex, a cofactor role rather than a gut effect. It complements mulberry, which acts entirely in the intestinal lumen.

Morus Alba + Glucomannan (Konjac)viscosity plus enzyme inhibition

Viscous konjac fibre slows gastric emptying and forms a diffusion barrier around starch, while mulberry DNJ blocks the alpha-glucosidase step that would release glucose from it. Slowing delivery and slowing hydrolysis stack on the same post-meal curve.

Morus Alba + Inulin (Chicory Root)additive colonic fermentation

Alpha-glucosidase inhibition pushes undigested carbohydrate further along the gut, where it is fermented, and inulin is itself a fully fermentable substrate. Taken together the gas and bloating load in the colon adds up, which is the usual tolerance limit for both.

Morus Alba + Ironpolyphenol chelation of non-heme iron

Mulberry leaf is rich in flavonoids and chlorogenic-type polyphenols, which form insoluble complexes with non-heme iron in the intestinal lumen. Iron taken in the same dose window is less available as a result.

Morus Alba + Alpha-lipoic acidEstablished pharmacology, no combination trial identified

Mulberry leaf acts in the gut lumen, where 1-deoxynojirimycin competes with dietary oligosaccharides at the brush-border alpha-glucosidases. Alpha-lipoic acid works after absorption, on glucose handling inside the cell. The two sit at different points of the same route, so a formulator can pair them without one blunting the other. No trial has measured the pair together, so read the combination as mechanistic.

Morus Alba + Bitter melonEstablished pharmacology, traditional co-formulation

Both are carbohydrate-handling botanicals that show up in the same blends. Mulberry leaf slows the enzymatic release of glucose from starch; bitter melon constituents act mainly on post-absorptive glucose uptake. Because the sites differ, the effects are plausibly additive rather than redundant. Anyone already using glucose-lowering medication should have the stack reviewed by their clinician, since additive effects are the point here.

Morus Alba + Psyllium huskEstablished pharmacology, shared postprandial mechanism

Psyllium raises the viscosity of gut contents, which slows gastric emptying and the rate at which starch reaches the brush border. Mulberry leaf then limits the final hydrolysis step at that border. Slowing delivery and slowing cleavage stack cleanly onto one another. Separate the pair from other supplements by a couple of hours, because viscous fibre delays absorption generally.

Partially hydrolysed guar gum keeps some of the viscosity of the parent gum while staying easier to disperse in a drink. Alongside mulberry leaf it moderates how fast a carbohydrate load presents to the enzyme surface. The pairing is formulation convention in powdered pre-meal blends. It has not been measured as a fixed combination.

Morus Alba + Beta-glucan (oat)Established pharmacology

Oat beta-glucan is a viscous fibre with a regulatory record for moderating the postprandial glucose rise. Mulberry leaf contributes an enzyme-level brake on the same meal. The mechanisms are independent, so both can operate on one carbohydrate load. Dose beta-glucan high enough to build viscosity or the fibre side contributes little.

Morus Alba + Green tea extract (EGCG)Established pharmacology, in vitro enzyme work

Catechins inhibit alpha-amylase and, to a lesser degree, alpha-glucosidase in vitro. Mulberry leaf iminosugars hit alpha-glucosidase specifically and with much higher affinity. Together they cover both the amylase step and the brush-border step of starch breakdown. This is enzyme-level evidence, not a measured human outcome for the pair.

Morus Alba + QuercetinEstablished phytochemistry

Mulberry leaf already carries quercetin and its glycosides as native constituents, so added quercetin extends a flavonoid profile the extract contains rather than introducing a foreign one. Flavonol glycosides contribute their own weak carbohydrase inhibition alongside the iminosugar fraction. Standardised extracts vary widely in flavonol content, so the added amount is what determines the contribution.

Morus Alba + RutinEstablished phytochemistry

Rutin is quercetin-3-rutinoside and a recognised marker compound in mulberry leaf material. Formulas that add it are topping up a class the leaf already provides. Gut bacteria cleave the sugar before much absorption happens, so the practical exposure is to quercetin either way.

Morus Alba + ZincEstablished pharmacology, absorption competition

Polyphenols and tannins in leaf material bind divalent minerals in the gut and lower the fraction of zinc taken up. This is the same chelation chemistry that makes tea a poor companion to a mineral tablet. Separating a mulberry leaf dose from a zinc dose by about two hours keeps the interaction out of the way. The direction here is competitive, not supportive.

Morus Alba + Vitamin CEstablished pharmacology

Ascorbate reduces ferric iron to the ferrous form and keeps it soluble, which partly offsets the mineral binding that plant polyphenols cause at the same meal. Taken with a mulberry leaf preparation it protects non-heme iron uptake rather than adding any glucose-related effect. Read this as an absorption correction, nothing more.

Morus Alba + Resistant starchEstablished pharmacology

When brush-border hydrolysis is slowed, more carbohydrate reaches the colon and becomes substrate for fermentation. Resistant starch is deliberately delivered to the same place. The two therefore feed one microbial process from different directions. The visible trade-off is gas and bloating in the first week, which usually settles with a slow build.

Morus Alba + Digestive enzymesEstablished pharmacology, opposing actions

Supplemental amylase and glucoamylase are added to speed starch breakdown. Mulberry leaf is added to slow it. Taken in the same meal they work against each other and the carbohydrate-moderating intent of the leaf extract is lost. Anyone using a broad digestive enzyme blend should space it from a pre-meal mulberry dose.

Who should be cautious

Nothing specific on file for Morus Alba. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Morus Alba actually does.

Established

Mulberry leaf carries 1-deoxynojirimycin, a sugar look-alike close enough to glucose to park in the gut's carb-splitting enzymes, so starch gets broken down more slowly and glucose enters the blood more gradually after a starchy meal.

Established

The effect is a competition inside the gut, so the extract has to arrive with or just before the carbs. Taken away from food, there's nothing there to compete with.

Established

Carbohydrate that escapes digestion in the small intestine moves on to the colon, where bacteria ferment it. That's why gas, bloating and loose stools show up first at higher doses. It comes straight from the intended mechanism, not a separate problem.

Established

The leaf also brings flavonol glycosides, mainly rutin and quercetin derivatives, plus chlorogenic acid. These account for the antioxidant profile seen in lab studies and are a different chemical family from the sugar mimics behind the enzyme effect.

Grown, 5 steps on record

Where Morus Alba comes from.

It starts as mulberry leaves from farmed trees. The leaves are dried, soaked to pull out the water-soluble actives, sometimes cleaned up further to concentrate them, tested to confirm how much of the key compound is present, then dried into a powder that goes into capsules.

Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.

Starts as
Morus alba leaf

Leaves of the white mulberry, mostly from cultivated stands in China, Japan, Korea and India where the tree is also grown for sericulture. Leaf age at harvest changes the iminosugar content.

Extracted by
Aqueous or hydroalcoholic extraction

Dried leaf is milled and extracted with water or a water-ethanol mix. Iminosugars are highly water soluble, so aqueous systems recover them well; higher ethanol fractions pull more flavonols.

Purified by
Ion-exchange or resin polishing

Some producers pass the extract over ion-exchange resin to concentrate the basic iminosugar fraction and drop sugars and pigment. Others skip this and sell a lower-percentage extract.

Standardised to
Assay to a stated DNJ percentage

Content is set against a reference standard, usually by HPLC with derivatisation or by LC-MS. Method differences are the main reason two extracts labelled the same can differ.

Ends up as
Spray-dried powder on a carrier

The concentrate is dried onto maltodextrin or a similar carrier, then blended, encapsulated or tabletted.

Getting Morus Alba from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Mulberry leaf tea, brewedFresh mulberriesDried mulberry leaf, culinary

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

White mulberry leaf extract, DNJ standardisedHydroalcoholic or water extract of Morus alba leaf, assayed for iminosugar content, typically expressed as a percentage of DNJFits Pre-meal use where the carbohydrate-moderating action is the point, because the active fraction is quantified rather than assumedTrade-off Standardisation adds cost and the assay method varies between suppliers, so two extracts at the same stated percentage are not necessarily interchangeable
Whole dried leaf powderDried, milled leaf with no solvent step; iminosugar and flavonol content follow the harvest rather than a specificationFits Traditional whole-plant use and tea preparations, where the full leaf matrix is wantedTrade-off Active content is unstated and varies by cultivar, leaf age and season, so the delivered amount of DNJ is unknown
Mulberry fruit (anthocyanin) extractExtract of the ripe fruit, standardised on anthocyanins such as cyanidin-3-glucoside rather than on iminosugarsFits Formulas built around fruit polyphenols and colour-bearing compoundsTrade-off A different chemistry from the leaf; it does not deliver the alpha-glucosidase-active fraction, so the two are not substitutes
Root bark extractExtract of the root bark, carrying prenylated flavonoids and stilbenes such as mulberroside, again distinct from the leaf iminosugarsFits Traditional East Asian formulations that specify the root bark by nameTrade-off Sparse modern human data, and the constituent profile does not overlap much with leaf extracts
What the strongest studies found

The essence, in one line each.

  1. Pooled trials found mulberry leaf or mulberry leaf extract lowered post-meal and fasting blood glucose readings.Meta-analysis. Cui et al., 2023 (Food & function). PMID 36644880
  2. Adding mulberry leaf and corn silk extract to lactose-hydrolysed milk reduced the rise in blood glucose after the drink.Randomised trial. Sun et al., 2025 (Clinical nutrition ESPEN). PMID 40187731
  3. Adults with sleep complaints taking mulberry leaf extract with tryptophan reported better sleep quality and better mood on waking than placebo.Randomised trial. Soon et al., 2025 (European journal of nutrition). PMID 40072601
  4. Mulberry leaf extract shifted metabolic, inflammatory and oxidative stress markers in the supplemented group; these are laboratory markers, not clinical outcomes.Randomised trial. Taghizadeh et al., 2022 (Clinical Nutrition ESPEN). PMID 35623877
  5. The review gathers mechanistic and clinical work on mulberry extract acting on metabolic risk factors and concludes the human evidence base remains early.Narrative review. Yu et al., 2025 (International Journal of Molecular Sciences). PMID 40943306
  6. A multi-ingredient supplement containing mulberry-derived material lowered post-meal glucose and insulin readings after a carbohydrate-rich challenge; the effect belongs to the blend, not to any single component.Open-label trial. Venugopal et al., 2024 (Nutrients). PMID 39064681
  7. A nutraceutical combination naming mulberry among its components moved both lipid and glucose measures in participants at cardiometabolic risk; the design cannot separate the ingredients.Open-label trial. Pacella et al., 2025 (Cardiovascular Diabetology). PMID 41044582
  8. Mulberry leaf supplementation improved glycaemic measures in the model, while no difference was detected in renal or cardiovascular markers, which is a failure to detect rather than evidence of no effect.Animal study. Gryn-Rynko et al., 2026 (Journal of Physiology and Pharmacology). PMID 42272281
  9. Preclinical work on berry and mulberry extracts reports antioxidant activity in cardiac tissue models; the findings are mechanistic and do not transfer to people.Animal study. Symeonidi et al., 2026 (Phytotherapy Research). PMID 42215287
  10. Selected berry varieties including mulberry acted on oxidative stress and insulin signalling markers in the animal models used; marker changes only.Animal study. Mohammed et al., 2026 (Brain and Behavior). PMID 42015507
  11. Feeding Morus alba leaf produced a distinct gut microbial profile compared with an alternative feed; the finding is about the leaf as a feed substrate in an insect species.Animal study. Shafique et al., 2026 (Open Veterinary Journal). PMID 42375244

These are the studies our verdict leans on, chosen from the 1,512 we read for Morus Alba. The full linked list is below.

Primary evidence

The studies, linked.

4 sources behind our Morus Alba verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.

  1. ClinicalTrials.gov
  2. ClinicalTrials.gov
  3. ClinicalTrials.gov
  4. ClinicalTrials.gov

Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.

Side effects reported to the FDA

Problems people have reported.

Read this carefully. These are 66 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Morus Alba is, not how risky it is. A report is not proof Morus Alba caused anything. It is a signal of what to watch for, nothing more.

Injection Site Reaction
5
Anaphylactic Reaction
4
Chest Discomfort
3
Flushing
3
Administration Site Discolouration
2
Arthralgia
2

Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.